GAMMA Investing LLC Purchases 296 Shares of Doximity, Inc. (NASDAQ:DOCS)

GAMMA Investing LLC lifted its position in Doximity, Inc. (NASDAQ:DOCS) by 20.6% during the 4th quarter, HoldingsChannel reports. The firm owned 1,735 shares of the company’s stock after buying an additional 296 shares during the period. GAMMA Investing LLC’s holdings in Doximity were worth $93,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in DOCS. Natixis Advisors LLC increased its holdings in shares of Doximity by 13.7% in the second quarter. Natixis Advisors LLC now owns 22,171 shares of the company’s stock worth $620,000 after purchasing an additional 2,675 shares during the period. Arizona State Retirement System increased its stake in Doximity by 2.4% in the second quarter. Arizona State Retirement System now owns 30,779 shares of the company’s stock valued at $861,000 after acquiring an additional 725 shares during the last quarter. Los Angeles Capital Management LLC bought a new position in Doximity in the second quarter valued at $287,000. Quest Partners LLC increased its stake in Doximity by 50,541.2% in the second quarter. Quest Partners LLC now owns 8,609 shares of the company’s stock valued at $241,000 after acquiring an additional 8,592 shares during the last quarter. Finally, American Century Companies Inc. increased its stake in Doximity by 0.9% in the second quarter. American Century Companies Inc. now owns 209,772 shares of the company’s stock valued at $5,867,000 after acquiring an additional 1,786 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Trading Down 5.6 %

Doximity stock opened at $51.94 on Friday. The firm has a 50-day moving average of $53.07 and a 200-day moving average of $41.59. The firm has a market cap of $9.70 billion, a P/E ratio of 59.70, a P/E/G ratio of 4.16 and a beta of 1.38. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75.

Analyst Upgrades and Downgrades

DOCS has been the topic of a number of research analyst reports. Stephens initiated coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 target price on the stock. Wells Fargo & Company raised Doximity from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $19.00 to $41.00 in a research note on Friday, November 8th. Canaccord Genuity Group cut Doximity from a “buy” rating to a “hold” rating and increased their target price for the company from $40.00 to $60.00 in a research note on Wednesday, November 13th. Evercore ISI increased their target price on Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, The Goldman Sachs Group started coverage on Doximity in a research note on Friday, November 15th. They set a “neutral” rating and a $58.00 price objective on the stock. Thirteen analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $53.00.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.